title: Synthesis and antimalarial effects of N2-aryl-N4-[(dialkylamino)alkyl]- and N4-aryl-N2-[(dialkylamino)alkyl]-2,4-quinazolinediamines.
abstract: A series of N2(and N4)-aryl-N4(and N2)-[(dialkylamino)alkyl]-2,4-quinazolinediamines has been synthesized for antimalarial evaluation. Condensation of the appropriate 2,4-dichloroquinazoline (IV) with the requisite N,N-dialkylalkylenediamine afforded a series of 2-chloro-N-[(dialkylamino)alkyl]-4-quinazolinamines (V) which were condensed with the appropriate arylamine to provide the corresponding N2-aryl-N4-[(dialkylamino)alkyl]-2,4-quinazolinediamines (VI). Hydrolysis of 2,4-dichloroquinazoline to 2-chloro-4-quinazolinol was followed by condensation with the appropriate N,N-dialkylalkylenediamine to give an array of 2-[[(dialkylamino)alkyl]amino]-4-quinazolinols (IXa). Chlorination with phosphorus oxychloride and condensation with a requisite arylamine provided the N2-[(dialkylamino)alkyl]-N4-phenyl-2,4-quinazolinediamines (X). Antimalarial activity was general among the N2-aryl-N4-[(dialkylamino)alkyl]-2,4-quinazolinediamines (VI), while the reverse isomers were of lower activity. Phototoxic liability precluded clinical evaluation of a member of the series.
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis*; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects; D011799:Quinazolines / Q000138:chemical synthesis* / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D000962:Antimalarials; D011799:Quinazolines